, Population-based vs hospital-based studies

, Article 1 -Variation of ALS occurrence between populations

I. Chapter, Amyotrophic lateral sclerosis in Africa

. .. Africa, Results: Sociodemographic, clinical features, prognoses and survival of ALS patients -The TROPALS study, The epidemiological study of ALS in the tropics (TROPALS): focus on

, 3.6. Diagnosis criteria and progression of disability: The TROPALS study

, Conclusion: The TROPALS study

, Article 2 -Clinical features and prognosis of ALS in Africa

. .. Chapter-;-america, 1.1.3. ALS occurrence between geographic areas and ethnic groups in Latin America

, Clinical characteristics of ALS in Latin America

. .. Ecuador, 128 IV.2.1. Methodological design: ALS mortality study in Ecuador, Amyotrophic lateral sclerosis mortality study in

J. A. References-aarli, A. G. Diop, and H. Lochmüller, Neurology in sub-Saharan Africa: a challenge for World Federation of Neurology, Neurology, vol.69, pp.1715-1718, 2007.

,

M. N. Abdulla, T. E. Sokrab, A. Tahir, H. E. Siddig, and M. E. Ali, Motor neurone disease in the tropics: findings from Sudan, East Afr. Med. J, vol.74, pp.46-48, 1997.

S. Abrahams and T. Bak, Edinburgh Cognitive and Behavioural ALS Screen -ECAS English version, 2013.

A. M. Adam, Unusual form of motor neuron disease in Kenya, East Afr. Med. J, vol.69, pp.55-57, 1992.

A. Alavi, S. Nafissi, M. Rohani, B. Zamani, B. Sedighi et al., Genetic analysis and SOD1 mutation screening in Iranian amyotrophic lateral sclerosis patients, Neurobiol. Aging, vol.34, pp.1516-1517, 2013.

S. Alcaz, M. Jarebinski, T. Pekmezovi?, Z. Stevi?-marinkovi?, S. Pavlovi? et al., Epidemiological and clinical characteristics of ALS in Belgrade, Acta Neurol. Scand, vol.94, pp.264-268, 1996.

A. Al-chalabi and O. Hardiman, The epidemiology of ALS: a conspiracy of genes, environment and time, Nat. Rev. Neurol, vol.9, pp.617-628, 2013.

,

A. Alonso, G. Logroscino, S. S. Jick, and M. A. Hernán, Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study, BMC Neurol, vol.10, 2010.

P. M. Andersen, P. Nilsson, M. L. Keränen, L. Forsgren, J. Hägglund et al., Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia, Brain J. Neurol, vol.120, pp.1723-1737, 1997.

N. B. Anderson, R. A. Bulatao, and B. Cohen, National Research Council (US) Panel on Race, Ethnic Differences in Dementia and Alzheimer's Disease, 2004.

J. F. Annegers, S. Appel, J. R. Lee, and P. Perkins, Arch. Neurol, vol.48, pp.589-593, 1985.

C. Armon, Smoking may be considered an established risk factor for sporadic ALS, Neurology, vol.73, pp.1693-1698, 2009.

A. Arnold, D. C. Edgren, and V. S. Palladino, Amyotrophic lateral sclerosis; fifty cases observed on Guam, J. Nerv. Ment. Dis, vol.117, pp.135-139, 1953.

K. C. Arthur, A. Calvo, T. R. Price, J. T. Geiger, A. Chiò et al., Projected increase in amyotrophic lateral sclerosis from 2015 to 2040, Nat. Commun, vol.7, 2016.

I. O. Azuonye, Describing race, ethnicity, and culture in medical research. Guidelines will encourage the thinking that underpins racism in medicine, BMJ, vol.313, p.426, 1996.

B. Villacís and D. Carrillo, Estadística Demográfica en el Ecuador: Diagnostico y Propuesta, 2011.

, Licence CC BY

S. A. Banack, S. J. Murch, and P. A. Cox, Neurotoxic flying foxes as dietary items for the Chamorro people, Marianas Islands, J. Ethnopharmacol, vol.106, pp.97-104, 2006.

E. Beeldman, J. Raaphorst, M. Klein-twennaar, M. De-visser, B. A. Schmand et al., The cognitive profile of ALS: a systematic review and meta-analysis update, 2016.

, J. Neurol. Neurosurg. Psychiatry, vol.87, pp.611-619

E. Beghi, C. Balzarini, G. Bogliun, G. Logroscino, L. Manfredi et al., Reliability of the El Escorial diagnostic criteria for amyotrophic lateral sclerosis, Neuroepidemiology, vol.21, pp.265-270, 2002.

E. Beghi, G. Logroscino, A. Chiò, O. Hardiman, D. Mitchell et al., The epidemiology of ALS and the role of population-based registries, Biochim. Biophys. Acta, vol.1762, pp.1150-1157, 2006.

,

M. Ben-hamida and F. Hentati, Charcot's disease and juvenile amyotrophic lateral sclerosis, Rev. Neurol, vol.140, pp.202-206, 1984.

M. Ben-hamida, F. Hentati, and C. Ben-hamida, Conditions combining a bilateral pyramidal syndrome with limb and bulbar amyotrophy, Brain J. Neurol, vol.113, pp.347-363, 1990.

D. A. Bennett, C. Brayne, V. L. Feigin, S. Barker-collo, M. Brainin et al., Development of the Standards of Reporting of Neurological Disorders (STROND) checklist: A guideline for the reporting of incidence and prevalence studies in neuroepidemiology, Neurology, vol.85, pp.821-828, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01262351

M. Bettini, G. M. Gargiulo-monachelli, G. Rodríguez, R. C. Rey, L. M. Peralta et al., Epidemiology of amyotrophic lateral sclerosis patients in a centre in Buenos Aires, Arq. Neuropsiquiatr, vol.69, pp.867-870, 2011.

M. Bettini, J. Vicens, D. H. Giunta, M. Rugiero, and E. Cristiano, Incidence and prevalence of amyotrophic lateral sclerosis in an HMO of, Amyotroph. Lateral Scler. Front. Degener, vol.14, pp.598-603, 2013.

,

N. Bharucha, P. Odermatt, and P. Preux, Methodological difficulties in the conduct of neuroepidemiological studies in low-and middle-income countries, Neuroepidemiology, vol.42, pp.7-15, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01208438

R. Bhopal and L. Donaldson, White, European, Western, Caucasian, or what? Inappropriate labeling in research on race, ethnicity, and health, Am. J. Public Health, vol.88, pp.1303-1307, 1998.

A. Bougteba, A. Basir, N. Birouk, H. Belaidi, B. Kably et al., Sclérose latérale amyotrophique au Maroc. Etude de 276 cas, Journ. Neurol. Lang. Fr, vol.161, p.97, 2005.

F. Boumediene, B. Marin, and P. Preux, Chapter 1 -Methodological Challenges of Neuroepidemiological Studies in Low-and Middle-Income Countries, Neuroepidemiology in Tropical Health, pp.3-12, 2018.

W. G. Bradley and D. C. Mash, Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases, Amyotroph. Lateral Scler. Off, 2009.

, Licence CC BY

, Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis, vol.10

A. Brockington, J. Kirby, D. Eggitt, E. Schofield, C. Morris et al., Screening of the regulatory and coding regions of vascular endothelial growth factor in amyotrophic lateral sclerosis, Neurogenetics, vol.6, pp.101-104, 2005.

B. R. Brooks, El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors, J. Neurol. Sci, vol.124, pp.96-107, 1994.

B. R. Brooks, R. G. Miller, M. Swash, and T. L. Munsat, El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis, Amyotroph. Lateral Scler. Mot. Neuron Disord. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis, vol.1, pp.293-299, 2000.

R. H. Brown and A. Al-chalabi, Amyotrophic Lateral Sclerosis. N. Engl. J. Med, vol.377, pp.162-172, 2017.

M. Bucheli, A. Andino, M. Montalvo, J. Cruz, N. Atassi et al., Amyotrophic lateral sclerosis: analysis of ALS cases in a predominantly admixed population of Ecuador, Amyotroph. Lateral Scler. Front. Degener, vol.15, pp.106-113, 2014.

M. E. Bucheli, A. Calderón, D. Chicaiza, C. Franco, R. López et al., Feedback interaction of research, advocacy, and clinical care applied to ALS research in South America, Neurology, vol.81, pp.1959-1961, 2013.

S. Byrne, M. Elamin, P. Bede, A. Shatunov, C. Walsh et al., Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study, Lancet Neurol, vol.11, pp.232-240, 2012.

S. Byrne, I. Jordan, M. Elamin, and O. Hardiman, Age at onset of amyotrophic lateral sclerosis is proportional to life expectancy, Amyotroph. Lateral Scler. Front. Degener, vol.14, pp.604-607, 2013.

S. Byrne, C. Walsh, C. Lynch, P. Bede, M. Elamin et al., Rate of familial amyotrophic lateral sclerosis: a systematic review and metaanalysis, J. Neurol. Neurosurg. Psychiatry, vol.82, pp.623-627, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00591173

,

J. M. Cedarbaum, N. Stambler, E. Malta, C. Fuller, D. Hilt et al., The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III), J. Neurol. Sci, vol.169, pp.13-21, 1999.

R. Chakraborty, DNA polymorphism and clinical genetics, Indian J. Pediatr, vol.53, pp.781-790, 1986.

A. M. Chancellor and C. P. Warlow, Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950, J. Neurol. Neurosurg. Psychiatry, vol.55, pp.1106-1115, 1992.

H. Chen, M. Richard, D. P. Sandler, D. M. Umbach, and F. Kamel, Head Injury and Amyotrophic Lateral Sclerosis, Am. J. Epidemiol, vol.166, pp.810-816, 2007.

,

, Licence CC BY

W. Chen, M. Saeed, H. Mao, N. Siddique, L. Dellefave et al., Lack of association of VEGF promoter polymorphisms with sporadic ALS, Neurology, vol.67, pp.508-510, 2006.

R. Chia, A. Chiò, and B. J. Traynor, Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications, Lancet Neurol, vol.17, pp.94-102, 2018.

A. Chiò, G. Benzi, M. Dossena, R. Mutani, and G. Mora, Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players, Brain J. Neurol, vol.128, pp.472-476, 2005.

A. Chiò, G. Borghero, M. Pugliatti, A. Ticca, A. Calvo et al., Italian Amyotrophic Lateral Sclerosis Genetic (ITALSGEN) Consortium, 2011a. Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene, Arch. Neurol, vol.68, pp.594-598

A. Chiò, E. Bottacchi, C. Buffa, R. Mutani, G. Mora et al., Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities, J. Neurol. Neurosurg. Psychiatry, vol.77, pp.948-950, 2006.

,

A. Chiò, A. Calvo, C. Moglia, L. Mazzini, and G. Mora, Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study, J. Neurol. Neurosurg. Psychiatry, vol.82, pp.740-746, 2011.

A. Chiò, A. Ilardi, S. Cammarosano, C. Moglia, A. Montuschi et al., Neurobehavioral dysfunction in ALS has a negative effect on outcome and use of PEG and NIV, Neurology, vol.78, pp.1085-1089, 2012.

A. Chiò, G. Logroscino, O. Hardiman, R. Swingler, D. Mitchell et al., Prognostic factors in ALS: A critical review, Amyotroph. Lateral Scler. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis, vol.10, pp.310-323, 2009.

A. Chiò, G. Logroscino, B. J. Traynor, J. Collins, J. C. Simeone et al., Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature, Neuroepidemiology, vol.41, pp.118-130, 2013.

,

A. Chiò, C. Magnani, E. Oddenino, G. Tolardo, and D. Schiffer, Accuracy of death certificate diagnosis of amyotrophic lateral sclerosis, J. Epidemiol. Community Health, vol.46, pp.517-518, 1992.

A. Chiò, C. Magnani, and D. Schiffer, Amyotrophic lateral sclerosis mortality in Italy, 1958 to 1987: a cross-sectional and cohort study, Neurology, vol.43, pp.927-930, 1993.

A. Chió, P. Meineri, A. Tribolo, and D. Schiffer, Risk factors in motor neuron disease: a case-control study, Neuroepidemiology, vol.10, pp.174-184, 1991.

,

A. Chiò, G. Mora, M. Leone, L. Mazzini, D. Cocito et al., Early symptom progression rate is related to ALS outcome: a prospective population-based study, Neurology, vol.59, pp.99-103, 2002.

, Licence CC BY

V. P. Cintra, L. C. Bonadia, H. M. Andrade, M. De-albuquerque, M. F. Eusébio et al., The frequency of the C9orf72 expansion in a Brazilian population, Neurobiol. Aging, vol.66, pp.1-179, 2018.

H. Collomb, R. Virieu, M. Dumas, and G. Lemercier, Maladie de Charcot et syndromes de sclérose latérale amyotrophique au Sénégal. Etude clinique de 27 observations, Bull Soc M É Afr Noire Lgue Fr, pp.785-804, 1968.

J. E. Cosnett, P. L. Bill, and A. I. Bhigjee, Motor neuron disease in blacks. Epidemiological observations in Natal, South Afr. Med. J. Suid-Afr. Tydskr. Vir Geneeskd, vol.76, pp.155-157, 1989.

J. Costa, M. Swash, and M. De-carvalho, Awaji criteria for the diagnosis of amyotrophic lateral sclerosis:a systematic review, Arch. Neurol, vol.69, pp.1410-1416, 2012.

P. Couratier, P. Corcia, G. Lautrette, M. Nicol, and B. Marin, ALS and frontotemporal dementia belong to a common disease spectrum, Rev. Neurol. (Paris), vol.173, pp.273-279, 2017.

P. Couratier, P. Corcia, G. Lautrette, M. Nicol, P. Preux et al., Epidemiology of amyotrophic lateral sclerosis: A review of literature, Rev. Neurol, vol.172, pp.37-45, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01262730

P. Couratier, C. Truong, M. Khalil, F. Devière, and J. M. Vallat, Clinical features of flail arm syndrome, Muscle Nerve, vol.23, pp.646-648, 2000.

P. A. Cox, S. A. Banack, and S. J. Murch, Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam, Proc. Natl. Acad. Sci. U. S. A, vol.100, pp.13380-13383, 2003.

H. Creemers, H. Grupstra, F. Nollet, . Van-den, L. H. Berg et al., Prognostic factors for the course of functional status of patients with ALS: a systematic review, J. Neurol, vol.262, pp.1407-1423, 2015.

C. Crockford, J. Newton, K. Lonergan, T. Chiwera, T. Booth et al., ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS, Neurology, vol.91, pp.1370-1380, 2018.

,

S. Cronin, O. Hardiman, and B. J. Traynor, Ethnic variation in the incidence of ALS: a systematic review, Neurology, vol.68, pp.1002-1007, 2007.

,

A. Czaplinski, A. A. Yen, and S. H. Appel, Forced vital capacity (FVC) as an indicator of survival and disease progression in an ALS clinic population, J. Neurol. Neurosurg. Psychiatry, vol.77, pp.390-392, 2006.

N. Dahodwala, A. Siderowf, M. Xie, E. Noll, M. Stern et al., Racial Differences in the Diagnosis of Parkinson's Disease, Mov. Disord. Off. J. Mov. Disord. Soc, vol.24, pp.1200-1205, 2009.

E. D'amico, M. Pasmantier, Y. Lee, L. Weimer, and H. Mitsumoto, Clinical Evolution of Pure Upper Motor Neuron Disease/Dysfunction (PUMND), Muscle Nerve, vol.47, pp.28-32, 2013.

M. Dandaba, P. Couratier, A. Labrunie, M. Nicol, B. Hamidou et al., Characteristics and Licence CC BY-NC-ND 3.0 Prognosis of Oldest Old Subjects with Amyotrophic Lateral Sclerosis, Neuroepidemiology, vol.49, pp.64-73, 2017.

M. De-carvalho, R. Dengler, A. Eisen, J. D. England, R. Kaji et al., Electrodiagnostic criteria for diagnosis of ALS, Clin. Neurophysiol. Off. J. Int. Fed. Clin. Neurophysiol, vol.119, pp.497-503, 2008.

M. De-carvalho, T. Matias, F. Coelho, T. Evangelista, A. Pinto et al., Motor neuron disease presenting with respiratory failure, J. Neurol. Sci, vol.139, pp.117-122, 1996.

C. M. De-castro-costa, R. B. Oriá, J. A. Machado-filho, M. T. Franco, D. L. Diniz et al., Amyotrophic lateral sclerosis. Clinical analysis of 78 cases from Fortaleza (northeastern Brazil), Arq. Neuropsiquiatr, vol.57, pp.761-774, 1999.

S. W. De-jong, M. H. Huisman, N. A. Sutedja, A. J. Van-der-kooi, M. Visser et al., Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study, Am. J. Epidemiol, vol.176, pp.233-239, 2012.

G. Dean, M. Quigley, and M. Goldacre, Motor neuron disease in a defined English population: estimates of incidence and mortality, J. Neurol. Neurosurg. Psychiatry, vol.57, pp.450-454, 1994.

M. C. Dekker, S. J. Urasa, M. B. Aerts, and W. P. Howlett, Motor neuron disease in sub-Saharan Africa: case series from a Tanzanian referral hospital, J Neurol Neurosurg Psychiatry, 2018.

M. A. Del-aguila, W. T. Longstreth, V. Mcguire, T. D. Koepsell, and G. Van-belle, Prognosis in amyotrophic lateral sclerosis: a population-based study, Neurology, vol.60, pp.813-819, 2003.

D. Bo, R. Scarlato, M. Ghezzi, S. Martinelli-boneschi, F. Corti et al., Absence of angiogenic genes modification in Italian ALS patients, Neurobiol. Aging, vol.29, pp.314-316, 2008.

A. Delzor, P. Couratier, F. Boumédiène, M. Nicol, M. Druet-cabanac et al., Searching for a link between the L-BMAA neurotoxin and amyotrophic lateral sclerosis: a study protocol of the French BMAALS programme, BMJ Open, vol.4, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01073863

J. C. Desport, P. M. Preux, T. C. Truong, J. M. Vallat, D. Sautereau et al., Nutritional status is a prognostic factor for survival in ALS patients, Neurology, vol.53, pp.1059-1063, 1999.
URL : https://hal.archives-ouvertes.fr/hal-01083608

F. Dietrich-neto, D. Callegaro, E. Dias-tosta, H. A. Silva, M. E. Ferraz et al., Amyotrophic lateral sclerosis in Brazil: 1998 national survey, Arq. Neuropsiquiatr, vol.58, pp.607-615, 2000.

A. Diop, Neurology in Sub-Saharan Africa. Development, Opportunity, Hope and Challenges, 2014.

Y. Doi, N. Atsuta, G. Sobue, M. Mitsuya, and N. Imaharu, Prevalence and Incidence of Amyotrophic Lateral Sclerosis in Japan, J. Epidemiol, vol.24, pp.494-499, 2014.

, Licence CC BY

R. Douville, J. Liu, J. Rothstein, and A. Nath, Identification of active loci of a human endogenous retrovirus in neurons of patients with amyotrophic lateral sclerosis, Ann. Neurol, vol.69, pp.141-151, 2011.

P. M. Andersen, S. Abrahams, G. D. Borasio, M. De-carvalho, A. Chio et al., EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force, Eur. J. Neurol, vol.19, pp.360-375, 2012.

M. Elamin, J. Phukan, P. Bede, N. Jordan, S. Byrne et al., Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia, Neurology, vol.76, pp.1263-1269, 2011.

M. Elian and G. Dean, Motor neuron disease and multiple sclerosis among immigrants to England from the Indian subcontinent, the Caribbean, and east and west Africa, J. Neurol. Neurosurg. Psychiatry, vol.56, pp.454-457, 1993.

J. M. Elwood, Commentary: On representativeness, Int. J. Epidemiol, vol.42, pp.1014-1015, 2013.

F. Fang, R. Bellocco, M. A. Hernán, and W. Ye, Smoking, snuff dipping and the risk of amyotrophic lateral sclerosis--a prospective cohort study, Neuroepidemiology, vol.27, pp.217-221, 2006.

F. Fang, U. Hållmarker, S. James, C. Ingre, K. Michaëlsson et al., Amyotrophic lateral sclerosis among cross-country skiers in Sweden, Eur. J. Epidemiol, vol.31, pp.247-253, 2016.

R. Fernández-santiago, M. Sharma, J. C. Mueller, H. Gohlke, T. Illig et al., Possible gender-dependent association of vascular endothelial growth factor (VEGF) gene and ALS, Neurology, vol.66, pp.1929-1931, 2006.

K. C. Fitzgerald, É. J. O'reilly, G. J. Falcone, M. L. Mccullough, Y. Park et al., Dietary ?-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis, JAMA Neurol, vol.71, pp.1102-1110, 2014.

,

G. C. Fong, T. S. Cheng, K. Lam, W. K. Cheng, K. Y. Mok et al., An epidemiological study of motor neuron disease in Hong Kong, Amyotroph. Lateral Scler. Mot. Neuron Disord. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis, vol.6, pp.164-168, 2005.

K. Y. Fong, Y. L. Yu, Y. W. Chan, R. Kay, J. Chan et al., Motor neuron disease in Hong Kong Chinese: epidemiology and clinical picture, Neuroepidemiology, vol.15, pp.239-245, 1996.

,

R. B. Forbes, S. Colville, R. J. Swingler, A. Scottish, and . Register, The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over, Age Ageing, vol.33, pp.131-134, 2004.

M. T. Fullilove, Comment: abandoning "race" as a variable in public health research--an idea whose time has come, Am. J. Public Health, vol.88, pp.1297-1298, 1998.

A. Furby, K. Beauvais, I. Kolev, J. Rivain, and V. Sébille, Rural environment and risk factors of amyotrophic lateral sclerosis: a case-control study, J. Neurol, vol.257, pp.792-798, 2010.

, Licence CC BY

V. Gallo, N. Vanacore, H. B. Bueno-de-mesquita, R. Vermeulen, C. Brayne et al., Physical activity and risk of Amyotrophic Lateral Sclerosis in a prospective cohort study, Eur. J. Epidemiol, vol.31, pp.255-266, 2016.

A. García-redondo, O. Dols-icardo, R. Rojas-garcía, J. Esteban-pérez, P. Cordero-vázquez et al., Analysis of the C9orf72 gene in patients with amyotrophic lateral sclerosis in Spain and different populations worldwide, Hum. Mutat, vol.34, pp.79-82, 2013.

M. Gawel, Z. Zaiwalla, and F. C. Rose, Antecedent events in motor neuron disease, J. Neurol. Neurosurg. Psychiatry, vol.46, pp.1041-1043, 1983.

M. Gelfand, The Sick African. Cape Town: Stewart Printing Company, 1948.

I. Gijselinck, K. Sleegers, S. Engelborghs, W. Robberecht, J. Martin et al., Neuronal inclusion protein TDP-43 has no primary genetic role in FTD and ALS, Neurobiol. Aging, vol.30, pp.1329-1331, 2009.

C. G. Goetz, Amyotrophic lateral sclerosis: early contributions of Jean-Martin Charcot, Muscle Nerve, vol.23, pp.336-343, 2000.

K. Goh, S. Tian, N. Shahrizaila, C. Ng, and C. Tan, Survival and prognostic factors of motor neuron disease in a multi-ethnic Asian population, Amyotroph. Lateral Scler. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis, vol.12, pp.124-129, 2011.

P. H. Gordon, B. Cheng, I. B. Katz, H. Mitsumoto, and L. P. Rowland, Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS, Neurology, vol.72, pp.1948-1952, 2009.

P. H. Gordon, B. Cheng, I. B. Katz, M. Pinto, A. P. Hays et al., The natural history of primary lateral sclerosis, Neurology, vol.66, pp.647-653, 2006.

P. H. Gordon, J. M. Mehal, R. C. Holman, L. P. Rowland, A. S. Rowland et al., Incidence of amyotrophic lateral sclerosis among American Indians and Alaska natives, JAMA Neurol, vol.70, pp.476-480, 2013.

R. Govaarts, E. Beeldman, M. J. Kampelmacher, M. Van-tol, . Van-den et al., The frontotemporal syndrome of ALS is associated with poor survival, J. Neurol, vol.263, pp.2476-2483, 2016.

,

, Licence CC BY

M. J. Greenway, M. D. Alexander, S. Ennis, B. J. Traynor, B. Corr et al., A novel candidate region for ALS on chromosome 14q11, Neurology, vol.63, issue.2, pp.1936-1938, 2004.

M. J. Greenway, P. M. Andersen, C. Russ, S. Ennis, S. Cashman et al., ANG mutations segregate with familial and "sporadic" amyotrophic lateral sclerosis, Nat. Genet, vol.38, pp.411-413, 2006.

R. J. Guerreiro, J. C. Schymick, C. Crews, A. Singleton, J. Hardy et al., TDP-43 Is Not a Common Cause of Sporadic Amyotrophic Lateral Sclerosis, PLOS ONE, vol.3, 2008.

L. G. Gunnarsson, G. Lindberg, B. Söderfelt, and O. Axelson, The mortality of motor neuron disease in Sweden, Arch. Neurol, vol.47, pp.42-46, 1990.

L. Gunnarsson and R. Palm, Motor Neuron Disease and Heavy Manual Labor: An Epidemiologic Survey of Värmland County, Sweden. Neuroepidemiology, vol.3, pp.195-206, 1984.

K. Gwinn-hardy, J. L. Cummings, M. Poncet, and J. Hardy, Genotype -Proteotype -Phenotype Relationships in Neurodegenerative Diseases, Research and Perspectives in Alzheimer's Disease, pp.25-36, 2005.

B. Hamidou, P. Couratier, C. Besançon, M. Nicol, P. M. Preux et al., Epidemiological evidence that physical activity is not a risk factor for ALS, Eur. J. Epidemiol, vol.29, pp.459-475, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01086658

B. Hamidou, B. Marin, G. Lautrette, M. Nicol, W. Camu et al., Exploring the diagnosis delay and ALS functional impairment at diagnosis as relevant criteria for clinical trial enrolment, Amyotroph. Lateral Scler. Front. Degener, vol.18, pp.519-527, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01757319

O. Hardiman, A. A. Chalabi, C. Brayne, E. Beghi, . Van-den et al., The changing picture of amyotrophic lateral sclerosis: lessons from European registers, J. Neurol. Neurosurg. Psychiatry, 2017.

J. R. Harries, Amyotrophic lateral sclerosis in Africans, East Afr. Med. J, vol.32, pp.333-335, 1955.

L. J. Haverkamp, V. Appel, and S. H. Appel, Natural history of amyotrophic lateral sclerosis in a database population, Brain J. Neurol, vol.118, pp.707-719, 1995.

,

E. Højer-pedersen, P. B. Christensen, and N. B. Jensen, Incidence and prevalence of motor neuron disease in two Danish counties, Neuroepidemiology, vol.8, pp.151-159, 1989.

J. R. Homburger, A. Moreno-estrada, C. R. Gignoux, D. Nelson, E. Sanchez et al., Genomic Insights into the Ancestry and Demographic History of South America, PLOS Genet, vol.11, 2015.

E. B. Hook and R. R. Regal, Capture-recapture methods in epidemiology: methods and limitations, Epidemiol. Rev, vol.17, pp.243-264, 1995.

, Licence CC BY

M. T. Hu, C. M. Ellis, A. Al-chalabi, P. N. Leigh, and C. E. Shaw, Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis, J. Neurol. Neurosurg. Psychiatry, vol.65, pp.950-951, 1998.

M. H. Huisman, S. W. De-jong, P. T. Van-doormaal, S. S. Weinreich, H. J. Schelhaas et al., Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology, J. Neurol. Neurosurg. Psychiatry, vol.82, pp.1165-1170, 2011.

,

M. H. Huisman, M. Seelen, S. W. De-jong, K. R. Dorresteijn, P. T. Van-doormaal et al., Lifetime physical activity and the risk of amyotrophic lateral sclerosis, J. Neurol. Neurosurg. Psychiatry, vol.84, pp.976-981, 2013.

A. Huss, A. Spoerri, M. Egger, and M. Röösli, Residence near power lines and mortality from neurodegenerative diseases: longitudinal study of the Swiss population, Am. J. Epidemiol, vol.169, pp.167-175, 2009.

,

I. Imam and A. Ogunniyi, What is Happening to Motor Neuron Disease in Nigeria?, Ann. Afr. Med, vol.3, p.3, 2004.

F. Imounan, S. Lahbouje, Y. Hsaini, W. Regragui, E. H. Ait-ben-haddou et al., , 2015.

, Tunis. Med, vol.93, pp.365-370

P. G. Ince, J. Evans, M. Knopp, G. Forster, H. H. Hamdalla et al., Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS, Neurology, vol.60, pp.1252-1258, 2003.

, Instituto Nacional de Estadística y Censos, n.d. Censo Población y Vivienda

. Inst, . Nac, . Estad, ;. Censos, Z. Xi et al., Analysis of C9orf72 in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Argentina, Neurobiol. Aging, vol.40, 2016.

L. Jacquin-cotton, M. Dumas, and P. Girard, Les paraplégies au Sénégal, Bull Soc M É Afr Noire Lgue Fr, vol.15, pp.206-226, 1970.

J. Jang, M. Kwon, W. J. Choi, K. Oh, S. Koh et al., Analysis of the C9orf72 hexanucleotide repeat expansion in Korean patients with familial and sporadic amyotrophic lateral sclerosis, Neurobiol. Aging, vol.34, pp.1311-1318, 2013.

P. Joensen, Incidence of amyotrophic lateral sclerosis in the Faroe Islands, Acta Neurol. Scand, vol.126, pp.62-66, 2012.

L. Johnson, J. W. Miller, A. S. Gkazi, C. Vance, S. D. Topp et al., Screening for OPTN mutations in a cohort of British amyotrophic lateral sclerosis patients, Neurobiol. Aging, vol.33, pp.15-2948, 2012.

E. Kahana and N. Zilber, Changes in the incidence of amyotrophic lateral sclerosis in Israel, Arch. Neurol, vol.41, pp.157-160, 1984.

, Licence CC BY

M. Kamada, H. Maruyama, E. Tanaka, H. Morino, R. Wate et al., Screening for TARDBP mutations in Japanese familial amyotrophic lateral sclerosis, J. Neurol. Sci, vol.284, pp.69-71, 2009.

F. Kamel, D. M. Umbach, H. Hu, T. L. Munsat, J. M. Shefner et al., Lead exposure as a risk factor for amyotrophic lateral sclerosis, Neurodegener. Dis, vol.2, pp.195-201, 2005.

C. Karam, S. N. Scelsa, and D. J. Macgowan, The clinical course of progressive bulbar palsy, Amyotroph. Lateral Scler, vol.11, pp.364-368, 2010.

,

M. Kazamel, G. Cutter, G. Claussen, M. Alsharabati, S. J. Oh et al., Epidemiological features of amyotrophic lateral sclerosis in a large clinic-based African American population, Amyotroph. Lateral Scler. Front. Degener, vol.14, pp.334-337, 2013.

A. P. Kengne, A. Dzudie, and L. Dongmo, Epidemiological features of degenerative brain diseases as they occurred in Yaounde referral hospitals over a 9-year period, Neuroepidemiology, vol.27, pp.208-211, 2006.

M. C. Kiernan, S. Vucic, B. C. Cheah, M. R. Turner, A. Eisen et al., Amyotrophic lateral sclerosis, Lancet Lond. Engl, vol.377, issue.10, pp.61156-61163, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01785450

W. Kim, X. Liu, J. Sandner, M. Pasmantier, J. Andrews et al., Study of 962 patients indicates progressive muscular atrophy is a form of ALS, Neurology, vol.73, pp.1686-1692, 2009.

F. Kimura, C. Fujimura, S. Ishida, H. Nakajima, D. Furutama et al., Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS, Neurology, vol.66, pp.265-267, 2006.

,

K. Kimura, Endemiological and geomedical studies on amyotrophic lateral sclerosis and allied diseases in Kii Peninsula, Japan (preliminary report), Folia Psychiatr. Neurol. Jpn, vol.15, pp.175-181, 1961.

D. R. Koerner, Amyotrophic lateral sclerosis on Guam, Ann. Intern. Med, vol.37, pp.1204-1220, 1952.

M. R. Kolber and C. Scrimshaw, Family history of cardiovascular disease, Can. Fam. Physician, vol.60, p.1016, 2014.

K. Kollewe, U. Mauss, K. Krampfl, S. Petri, R. Dengler et al., ALSFRS-R score and its ratio: a useful predictor for ALS-progression, J. Neurol. Sci, vol.275, pp.69-73, 2008.

K. Kondo and T. Tsubaki, Changing mortality patterns of motor neuron disease in Japan, J. Neurol. Sci, vol.32, pp.411-424, 1977.

L. T. Kurland and D. W. Mulder, Epidemiologic investigations of amyotrophic lateral sclerosis. I. Preliminary report on geographic distribution, with special reference to the Mariana Islands, including clinical and pathologic observations, Neurology, vol.4, pp.355-378, 1954.

M. Kwon, W. Baek, C. Ki, H. Y. Kim, S. Koh et al., Screening of the SOD1, FUS, TARDBP, ANG, and OPTN mutations in Korean patients with familial and sporadic ALS, Neurobiol. Aging, vol.33, pp.1017-1034, 2012.

,

, Licence CC BY

C. Lai and H. Tseng, Epidemiology and medical expenses of motor neuron diseases in Taiwan, Neuroepidemiology, vol.31, pp.159-166, 2008.

D. Lambrechts, E. Storkebaum, M. Morimoto, J. Del-favero, F. Desmet et al., VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death, Nat. Genet, vol.34, pp.383-394, 2003.

A. Lannuzel, S. Mecharles, B. Tressières, A. Demoly, R. Alhendi et al., Clinical varieties and epidemiological aspects of amyotrophic lateral sclerosis in the Caribbean island of Guadeloupe: A new focus of ALS associated with Parkinsonism, Amyotroph. Lateral Scler. Front. Degener, vol.16, pp.216-223, 2015.

L. Bigot and P. , Profil épidémiologique des affections neurologiques au Gabon, pp.17-21, 1993.

J. R. Lee, J. F. Annegers, and S. H. Appel, Prognosis of amyotrophic lateral sclerosis and the effect of referral selection, J. Neurol. Sci, vol.132, pp.207-215, 1995.

E. J. Lehman, M. J. Hein, S. L. Baron, and C. M. Gersic, Neurodegenerative causes of death among retired National Football League players, Neurology, vol.79, pp.1970-1974, 2012.

A. Lekoubou, J. B. Echouffo-tcheugui, and A. P. Kengne, Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review, BMC Public Health, vol.14, 2014.

M. Leone, V. Chandra, and B. S. Schoenberg, Motor neuron disease in the United States 1971 and 1973-1978 patterns of mortality and associated conditions at the time of death, Neurology, vol.37, pp.1339-1343, 1987.

C. Li, Y. Ji, L. Tang, N. Zhang, J. He et al., Optineurin mutations in patients with sporadic amyotrophic lateral sclerosis in China, Amyotroph. Lateral Scler. Front. Degener, vol.16, pp.485-489, 2015.

N. M. Lima and A. Nucci, Clinical attention and assistance profile of patients with amyotrophic lateral sclerosis, Arq. Neuropsiquiatr, vol.69, pp.170-175, 2011.

E. Linden-junior, J. Becker, P. Schestatsky, F. T. Rotta, C. D. Marrone et al., Prevalence of amyotrophic lateral sclerosis in the city of Porto Alegre, in Southern Brazil, Arq. Neuropsiquiatr, vol.71, pp.959-962, 2013.

G. Logroscino, E. Beghi, S. Zoccolella, R. Palagano, A. Fraddosio et al., Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study, J. Neurol. Neurosurg. Psychiatry, vol.76, pp.1094-1098, 2005.

G. Logroscino, B. Marin, M. Piccininni, S. Arcuti, A. Chiò et al., Referral bias in ALS epidemiological studies, PloS One, vol.13, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01773975

G. Logroscino, M. Piccininni, B. Marin, E. Nichols, F. Abd-allah et al.,

M. M. Mehndiratta, A. H. Mokdad, G. Nagel, T. H. Nguyen, M. R. Nixon et al., Global, regional, and national burden of motor neuron diseases 1990-2016: a systematic analysis for the Global Burden of Disease Study, Lancet Neurol, vol.17, issue.18, pp.30404-30410, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02014301

G. Logroscino, R. Tortelli, G. Rizzo, B. Marin, P. M. Preux et al., Amyotrophic Lateral Sclerosis: An Aging-Related Disease, Curr. Geriatr. Rep, vol.4, pp.142-153, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01204855

G. Logroscino, B. J. Traynor, O. Hardiman, &. Chio, A. Couratier et al., Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues, J. Neurol. Neurosurg. Psychiatry, vol.79, pp.6-11, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00337671

M. P. Loureiro, C. H. Gress, L. C. Thuler, R. M. Alvarenga, and J. M. Lima, Clinical aspects of amyotrophic lateral sclerosis in Rio de Janeiro/Brazil, J. Neurol. Sci, vol.316, pp.61-66, 2012.

A. C. Ludolph and J. Brettschneider, TDP-43 in amyotrophic lateral sclerosis -is it a prion disease?, Eur. J. Neurol, vol.22, pp.753-761, 2015.

J. Luna, G. Logroscino, P. Couratier, and B. Marin, Current issues in ALS epidemiology: Variation of ALS occurrence between populations and physical activity as a risk factor, Rev. Neurol, vol.173, pp.244-253, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01556879

R. A. Lyall, N. Donaldson, M. I. Polkey, P. N. Leigh, and J. Moxham, Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis, Brain J. Neurol, vol.124, 2000.

E. Majounie, A. E. Renton, K. Mok, E. G. Dopper, A. Waite et al., Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study, Lancet Neurol, vol.11, pp.70043-70044, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00927546

A. M. Malek, A. Barchowsky, R. Bowser, A. Youk, and E. O. Talbott, Pesticide exposure as a risk factor for amyotrophic lateral sclerosis: a meta-analysis of epidemiological studies: pesticide exposure as a risk factor for ALS, Environ. Res, vol.117, pp.112-119, 2012.

B. Marin, F. Boumédiene, G. Logroscino, P. Couratier, M. Babron et al., Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis, Int. J. Epidemiol, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01320274

B. Marin, P. Couratier, S. Arcuti, M. Copetti, A. Fontana et al., Stratification of ALS patients' survival: a Licence CC BY-NC-ND 3.0 population-based study, J. Neurol, vol.263, pp.100-111, 2016.

B. Marin, P. Couratier, A. Lannuzel, and G. Logroscino, Chapter 13 -Other Neurocognitive Disorders in Tropical Health (Amyotrophic Lateral Sclerosis and Parkinson's Disease), in: Neuroepidemiology in Tropical Health, pp.167-183, 2018.

B. Marin, A. Fontana, S. Arcuti, M. Copetti, F. Boumédiene et al., Age-specific ALS incidence: a dose-response metaanalysis, Eur. J. Epidemiol, vol.33, pp.621-634, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01784577

B. Marin, B. Hamidou, P. Couratier, M. Nicol, A. Delzor et al., Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe--the French register of ALS in Limousin (FRALim register), Eur. J. Neurol, vol.21, pp.78-79, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01101244

B. Marin, I. Kacem, M. Diagana, M. Boulesteix, R. Gouider et al., Juvenile and adult-onset ALS/MND among Africans: incidence, phenotype, survival: a review, Amyotroph. Lateral Scler. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis, vol.13, pp.276-283, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00920819

,

B. Marin, G. Logroscino, F. Boumédiene, A. Labrunie, P. Couratier et al., Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin, Eur. J. Epidemiol, vol.31, pp.229-245, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01217277

C. Marin, P. Preux, P. Logroscino, and G. , Can mortality data be used to estimate amyotrophic lateral sclerosis incidence?, Neuroepidemiology, vol.36, pp.29-38, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00677285

D. Marin, J. C. Kajeu, P. Jesus, P. Nicolaud, B. Nicol et al., Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients, J. Neurol. Neurosurg. Psychiatry, vol.82, pp.628-634, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01113217

H. Maruyama, H. Morino, H. Ito, Y. Izumi, H. Kato et al., Mutations of optineurin in amyotrophic lateral sclerosis, Nature, vol.465, pp.223-226, 2010.

,

S. E. Matos, . De, M. T. Conde, F. M. Fávero, M. Taniguchi et al., Mortality rates due to amyotrophic lateral sclerosis in São Paulo City from, Arq. Neuropsiquiatr, vol.69, pp.861-866, 2002.

N. Matsumoto, R. M. Worth, L. T. Kurland, and H. Okazaki, Epidemiologic study of amyotrophic lateral sclerosis in Hawaii. Identification of high incidence among Filipino men, Neurology, vol.22, pp.934-940, 1972.

K. Mccluskey and L. Mccluskey, Racial disparity in mortality from ALS/ MND in US African Americans, Amyotroph Lateral Scler Mot. Neuron Disord, vol.5, pp.73-78, 2004.

L. Mccluskey, S. Vandriel, L. Elman, V. M. Van-deerlin, J. Powers et al., ALS-Plus syndrome: non-pyramidal features in a large ALS cohort, J. Neurol. Sci, vol.345, pp.118-124, 2014.

, Licence CC BY

V. Mcguire, W. T. Longstreth, T. D. Koepsell, and G. Van-belle, Incidence of amyotrophic lateral sclerosis in three counties in western Washington state, Neurology, vol.47, pp.571-573, 1996.

E. Meenakshisundaram, K. Jagannathan, and B. Ramamurthi, Clinical pattern of motor neuron disease seen in younger age groups in Madras, Neurol. India, vol.18, 1970.

K. M. Mehta, K. Yaffe, E. J. Pérez-stable, A. Stewart, D. Barnes et al., Race/ethnic differences in Alzheimer disease survival in US Alzheimer Disease Centers, Neurology, vol.70, pp.1163-1170, 2008.

,

H. Mentula, L. Tuovinen, S. Penttilä, T. Suominen, B. Udd et al., TARDBP mutations are not a frequent cause of ALS in Finnish patients, Acta Myol. Myopathies Cardiomyopathies Off. J. Mediterr. Soc. Myol, vol.31, pp.134-138, 2012.

J. Mielke and B. Adamolekun, Motor neuron disease in Zimbabwe, Congr. Pan Afr. Assoc. Neurol. Sci, 1996.

S. Millecamps, S. Boillée, I. L. Ber, D. Seilhean, E. Teyssou et al., Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes, J. Med. Genet, vol.49, pp.258-263, 2012.

S. Millecamps, F. Salachas, C. Cazeneuve, P. Gordon, B. Bricka et al., SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations, J. Med. Genet, vol.47, pp.554-560, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00557395

R. G. Miller, J. D. Mitchell, and D. H. Moore, Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND), Cochrane Database Syst. Rev. CD001447, 2012.

J. Mitchell and G. Borasio, Amyotrophic lateral sclerosis, The Lancet, vol.369, pp.2031-2041, 2007.
URL : https://hal.archives-ouvertes.fr/hal-01992234

S. M. Monroe, G. M. Slavich, and I. H. Gotlib, Life Stress and Family History for Depression: The Moderating Role of Past Depressive Episodes, J. Psychiatr. Res, vol.49, pp.90-95, 2014.

R. A. Montenegro and C. Stephens, Indigenous health in Latin America and the Caribbean, Lancet Lond. Engl, vol.367, pp.68808-68817, 2006.

A. Montuschi, B. Iazzolino, A. Calvo, C. Moglia, L. Lopiano et al., Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy, J. Neurol. Neurosurg. Psychiatry, vol.86, pp.168-173, 2015.

M. C. Moura, L. A. Casulari, and M. R. Carvalho-garbi-novaes, Ethnic and demographic incidence of amyotrophic lateral sclerosis (ALS) in Brazil: A population based study, Amyotroph. Lateral Scler. Front. Degener, vol.17, pp.275-281, 2016.

,

S. J. Murch, P. A. Cox, and S. A. Banack, A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam, Proc. Natl. Acad. Sci. U. S. A, vol.101, pp.12228-12231, 2004.

, Licence CC BY

S. J. Murch, P. A. Cox, S. A. Banack, J. C. Steele, and O. W. Sacks, Occurrence of betamethylamino-l-alanine (BMAA) in ALS/PDC patients from Guam, Acta Neurol. Scand, vol.110, pp.267-269, 2004.

M. Naghavi, A. A. Abajobir, C. Abbafati, K. M. Abbas, F. Abd-allah et al.,

I. Martopullo, C. Mcalinden, M. Mcgaughey, J. J. Mcgrath, S. Mehata et al., The Lancet, vol.390, pp.32152-32161, 2016.

I. Ndiaye, M. Ndiaye, M. Gueye, . Ndiaye, and . Mb, Les maladies dégénératives de la moelle, Congr. Pan Afr. Assoc. Neurol. Sci, 1986.

, Licence CC BY

D. Neary, J. S. Snowden, and D. M. Mann, Cognitive change in motor neurone disease/amyotrophic lateral sclerosis (MND/ALS), J. Neurol. Sci, vol.180, pp.15-20, 2000.

M. Nel, G. M. Agenbag, F. Henning, H. M. Cross, A. Esterhuizen et al., C9orf72 repeat expansions in South Africans with amyotrophic lateral sclerosis, J. Neurol. Sci, vol.401, pp.51-54, 2019.

L. M. Nelson, V. Mcguire, W. T. Longstreth, and C. Matkin, Population-based case-control study of amyotrophic lateral sclerosis in western Washington State. I. Cigarette smoking and alcohol consumption, Am. J. Epidemiol, vol.151, pp.156-163, 2000.

C. W. Noonan, M. C. White, D. Thurman, and L. Wong, Temporal and geographic variation in United States motor neuron disease mortality, Neurology, vol.64, pp.1215-1221, 1969.

, Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions on Rare Diseases -Europe's challenges, 2008.

K. Ogaki, Y. Li, N. Atsuta, H. Tomiyama, M. Funayama et al., Japanese Consortium for Amyotrophic Lateral Sclerosis research (JaCALS), 2012. Analysis of C9orf72 repeat expansion in 563 Japanese patients with amyotrophic lateral sclerosis, Neurobiol. Aging, vol.33, pp.2527-2538

H. Okumura, Epidemiological and clinical patterns of western pacific amyotrophic lateral sclerosis (ALS) in Guam and sporadic ALS, Hokkaido Igaku Zasshi, vol.78, pp.187-195, 2003.

L. Olivares, E. S. Estéban, and M. Alter, Mexican "resistance" to amyotrophic lateral sclerosis, Arch. Neurol, vol.27, pp.397-402, 1972.

R. K. Olney, J. Murphy, D. Forshew, E. Garwood, B. L. Miller et al., The effects of executive and behavioral dysfunction on the course of ALS, Neurology, vol.65, pp.1774-1777, 2005.

,

P. Orban, R. S. Devon, M. R. Hayden, and B. R. Leavitt, Handbook of Clinical Neurology, Motor Neuron Disorders and Related Diseases, pp.301-312, 2007.

B. O. Osuntokun, A. O. Adeuja, and O. Bademosi, The prognosis of motor neuron disease in Nigerian africans. A prospective study of 92 patients, Brain J. Neurol, vol.97, pp.385-394, 1974.

B. O. Osuntokun, A. O. Adeuja, B. S. Schoenberg, O. Bademosi, V. A. Nottidge et al., Neurological disorders in Nigerian Africans: a community-based study, Acta Neurol. Scand, vol.75, pp.13-21, 1987.

O. O'toole, B. J. Traynor, P. Brennan, C. Sheehan, E. Frost et al., Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and, J. Neurol. Neurosurg. Psychiatry, vol.79, pp.30-32, 2004.

,

R. Ottman, Gene-environment interaction: definitions and study designs, Prev. Med, vol.25, pp.764-770, 1996.

, Licence CC BY

J. Phukan, N. P. Pender, and O. Hardiman, Cognitive impairment in amyotrophic lateral sclerosis, Lancet Neurol, vol.6, pp.994-1003, 2007.

M. Piquemal, K. Beugre, F. Boa-yapo, and C. Giordano, Etude clinique de 30 observations de syndrome de sclérose latérale amyotrophique observés en Côte d'Ivoire, Afri J Neuro Sci, pp.31-40, 1982.

C. C. Plato, R. M. Garruto, D. Galasko, U. Craig, M. Plato et al., Amyotrophic lateral sclerosis and parkinsonism-dementia complex of Guam: changing incidence rates during the past 60 years, Am. J. Epidemiol, vol.157, pp.149-157, 2003.

R. S. Pobocik, J. J. Richer, and D. L. Hentges, Food Sources of Macronutrients in the Diets of Fifth Grade Children on Guam, Asian Am. Pac. Isl. J. Health, vol.7, pp.25-37, 1999.

P. M. Preux, P. Couratier, F. Boutros-toni, J. Y. Salle, F. Tabaraud et al., Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are independent risk factors, Neuroepidemiology, vol.15, pp.153-160, 1996.

T. Pringsheim, K. Wiltshire, L. Day, J. Dykeman, T. Steeves et al., The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis, Mov. Disord. Off. J. Mov. Disord. Soc, vol.27, pp.1083-1091, 2012.

E. Pupillo, P. Messina, G. Logroscino, E. Beghi, and . Slalom-group, Long-term survival in amyotrophic lateral sclerosis: a population-based study, Ann. Neurol, vol.75, pp.287-297, 2014.

K. Radhakrishnan, P. P. Ashok, R. Sridharan, and M. E. Mousa, Descriptive epidemiology of motor neuron disease in Benghazi, Libya. Neuroepidemiology, vol.5, pp.47-54, 1986.

P. Ragonese, G. Filippini, G. Salemi, E. Beghi, A. Citterio et al., Accuracy of death certificates for amyotrophic lateral sclerosis varies significantly from north to south of Italy: implications for mortality studies, Neuroepidemiology, vol.23, pp.73-77, 2004.

L. Rechtman, H. Jordan, L. Wagner, D. K. Horton, and W. Kaye, Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States, Amyotroph. Lateral Scler. Front. Degener, vol.16, pp.65-71, 2015.

,

D. T. Redden, J. Divers, L. K. Vaughan, H. K. Tiwari, T. M. Beasley et al., Regional Admixture Mapping and Structured Association Testing: Conceptual Unification and an Extensible General Linear Model, PLOS Genet, vol.2, 2006.

A. E. Renton, A. Chiò, and B. J. Traynor, State of play in amyotrophic lateral sclerosis genetics, Nat. Neurosci, vol.17, pp.17-23, 2014.

A. E. Renton, E. Majounie, A. Waite, J. Simón-sánchez, S. Rollinson et al.,

M. Consortium, D. Heckerman, E. Rogaeva, L. Zinman, J. D. Rothstein et al., A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD, Neuron, vol.72, pp.257-268, 2011.

J. E. Riggs, Amyotrophic lateral sclerosis, heterogeneous susceptibility, trauma, and epidemiology, Arch. Neurol, vol.53, pp.225-227, 1996.

,

G. M. Ringholz, S. H. Appel, M. Bradshaw, N. A. Cooke, D. M. Mosnik et al., Prevalence and patterns of cognitive impairment in sporadic ALS, Neurology, vol.65, pp.586-590, 2005.

G. M. Ringholz and S. R. Greene, The relationship between amyotrophic lateral sclerosis and frontotemporal dementia, Curr. Neurol. Neurosci. Rep, vol.6, pp.387-392, 2006.

G. A. Rippon, N. Scarmeas, P. H. Gordon, P. L. Murphy, S. M. Albert et al., An observational study of cognitive impairment in amyotrophic lateral sclerosis, Arch. Neurol, vol.63, pp.345-352, 2006.

,

W. Robberecht and T. Philips, The changing scene of amyotrophic lateral sclerosis, Nat. Rev. Neurosci, vol.14, pp.248-264, 2013.

A. L. Roberts, N. J. Johnson, J. T. Chen, M. E. Cudkowicz, and M. G. Weisskopf, Race/ethnicity, socioeconomic status, and ALS mortality in the United States, Neurology, vol.87, pp.2300-2308, 2016.

P. Rodríguez-paniagua, I. Salas-herrera, and M. Cartín-brenes, Incidencia de esclerosis lateral amiotrófica en Costa Rica, Acta Médica Costarric, vol.49, pp.33-37, 2007.

R. Rojas-garcia, K. M. Scott, J. C. Roche, W. Scotton, N. Martin et al., No evidence for a large difference in ALS frequency in populations of African and European origin: a population based study in inner city London, Amyotroph. Lateral Scler. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis, vol.13, pp.66-68, 2012.

,

G. Rosati, L. Pinna, E. Granieri, I. Aiello, R. Tola et al., Studies on Epidemiological, Clinical and Etiological Aspects of Als Disease in Sardinia, Southern Italy, Acta Neurol. Scand, vol.55, pp.231-244, 1977.

D. R. Rosen, T. Siddique, D. Patterson, D. A. Figlewicz, P. Sapp et al., Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis, Nature, vol.362, pp.59-62, 1993.

C. A. Ross and M. A. Poirier, Protein aggregation and neurodegenerative disease, Nat. Med, vol.10, pp.10-17, 2004.

K. J. Rothman, J. E. Gallacher, and E. E. Hatch, Why representativeness should be avoided, Int. J. Epidemiol, vol.42, pp.1012-1014, 2013.

L. P. Rowland, Progressive muscular atrophy and other lower motor neuron syndromes of adults, Muscle Nerve, vol.41, pp.161-165, 2010.

L. P. Rowland and N. A. Shneider, Amyotrophic lateral sclerosis, N. Engl. J. Med, vol.344, pp.1688-1700, 2001.

, Licence CC BY

C. D. Royal, J. Novembre, S. M. Fullerton, D. B. Goldstein, J. C. Long et al., Inferring Genetic Ancestry: Opportunities, Challenges, and Implications, Am. J. Hum. Genet, vol.86, pp.661-673, 2010.

M. Ryan, T. Vaillant, R. L. Mclaughlin, M. A. Doherty, J. Rooney et al., Comparison of the clinical and genetic features of amyotrophic lateral sclerosis across Cuban, Uruguayan and Irish clinic-based populations, J. Neurol. Neurosurg. Psychiatry, 2019.

M. Sabatelli, F. Madia, A. Conte, M. Luigetti, M. Zollino et al., Natural history of young-adult amyotrophic lateral sclerosis, Neurology, vol.71, pp.876-881, 2008.

M. Sajjadi, M. Etemadifar, A. Nemati, H. Ghazavi, K. Basiri et al., Epidemiology of amyotrophic lateral sclerosis in Isfahan, Iran, Eur. J. Neurol, vol.17, pp.984-989, 2010.

R. Santangelo, F. González-andrade, C. Børsting, A. Torroni, V. Pereira et al., Analysis of ancestry informative markers in three main ethnic groups from Ecuador supports a trihybrid origin of Ecuadorians, Forensic Sci. Int. Genet, vol.31, pp.29-33, 2017.

, STAT(R) 14.1 User's Guide, n.d. Comparing Directly Standardized Rates, SAS

D. A. Savitz, D. P. Loomis, and C. K. Tse, Electrical occupations and neurodegenerative disease: analysis of U.S. mortality data, Arch. Environ. Health, vol.53, pp.71-74, 1998.

P. L. Schiffman and J. M. Belsh, Pulmonary function at diagnosis of amyotrophic lateral sclerosis. Rate of deterioration, Chest, vol.103, pp.508-513, 1993.

A. Sedrak and N. P. Kondamudi, Sickle Cell Disease, 2019.

J. J. Sejvar, R. C. Holman, J. S. Bresee, K. D. Kochanek, and L. B. Schonberger, Amyotrophic Lateral Sclerosis Mortality in the United States, Neuroepidemiology, vol.25, pp.144-152, 1979.

M. F. Seldin, C. Tian, R. Shigeta, H. R. Scherbarth, G. Silva et al., Argentine population genetic structure: large variance in Amerindian contribution, Am. J. Phys. Anthropol, vol.132, pp.455-462, 2007.

F. Sene-diouf, M. Ndiaye, K. Toure, A. Ndao, A. Thiam et al., Aspects cliniques et épidémiologiques de la sclérose latérale amyotrophique à la clinique neurologique de Dakar. Dakar Méd, pp.167-71, 2004.

N. Shahrizaila, G. Sobue, S. Kuwabara, S. H. Kim, C. Birks et al., Amyotrophic lateral sclerosis and motor neuron syndromes in Asia, J. Neurol. Neurosurg. Psychiatry, vol.87, pp.821-830, 2016.

A. Shindo, Y. Ueda, S. Kuzuhara, and Y. Kokubo, Neuropsychological study of amyotrophic lateral sclerosis and parkinsonism-dementia complex in Kii peninsula, Japan. BMC Neurol, vol.14, p.151, 2014.

, Licence CC BY

C. L. Shoesmith, K. Findlater, A. Rowe, and M. J. Strong, Prognosis of amyotrophic lateral sclerosis with respiratory onset, J. Neurol. Neurosurg. Psychiatry, vol.78, pp.629-631, 2007.

D. Shriner and C. N. Rotimi, Whole-Genome-Sequence-Based Haplotypes Reveal Single Origin of the Sickle Allele during the Holocene Wet Phase, Am. J. Hum. Genet, vol.102, pp.547-556, 2018.

J. S. Snowden, J. Harris, A. Richardson, S. Rollinson, J. C. Thompson et al., Frontotemporal dementia with amyotrophic lateral sclerosis: A clinical comparison of patients with and without repeat expansions in C9orf72, Amyotroph. Lateral Scler. Front. Degener, vol.14, pp.172-176, 2013.

,

N. Stambler, M. Charatan, and J. M. Cedarbaum, Prognostic indicators of survival in ALS, ALS CNTF Treatment Study Group. Neurology, vol.50, pp.66-72, 1998.

D. E. Stickler, J. A. Royer, and J. W. Hardin, Accuracy and usefulness of ICD-10 death certificate coding for the identification of patients with ALS: results from the South Carolina ALS Surveillance Pilot Project, Amyotroph. Lateral Scler. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis, vol.13, pp.69-73, 2012.

,

B. Swinnen and W. Robberecht, The phenotypic variability of amyotrophic lateral sclerosis, Nat. Rev. Neurol, vol.10, pp.661-670, 2014.

M. C. Tartaglia, A. Rowe, K. Findlater, J. B. Orange, G. Grace et al., Differentiation Between Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis: Examination of Symptoms and Signs at Disease Onset and During Follow-up, Arch. Neurol, vol.64, pp.232-236, 2007.

R. Tekle-haimanot, M. Abebe, A. Gebre-mariam, L. Forsgren, J. Heijbel et al., Community-based study of neurological disorders in rural central Ethiopia, Neuroepidemiology, vol.9, pp.263-277, 1990.

D. Testa, R. Lovati, M. Ferrarini, F. Salmoiraghi, and G. Filippini, Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period, Amyotroph. Lateral Scler. Mot. Neuron Disord. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis, vol.5, pp.208-212, 2004.

, The United Nations Statistics Division, n.d. Demographic and Social Statistics [WWW Document

V. Thijs, E. Peeters, P. Theys, G. Matthijs, and W. Robberecht, Demographic characteristics and prognosis in a Flemish amyotrophic lateral sclerosis population, 2000.

, Acta Neurol. Belg, vol.100, pp.84-90

B. Tomik, A. Nicotra, C. M. Ellis, C. Murphy, S. Rabe-hesketh et al., Phenotypic differences between African and white patients with motor neuron disease: a case-control study, J. Neurol. Neurosurg. Psychiatry, vol.69, pp.251-253, 2000.

B. J. Traynor, M. Alexander, B. Corr, E. Frost, and O. Hardiman, Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, J. Neurol. Neurosurg. Psychiatry, vol.74, pp.1258-1261, 1996.

O. B. Tysnes, S. E. Vollset, and J. A. Aarli, Epidemiology of amyotrophic lateral sclerosis in Hordaland county, western Norway, Acta Neurol. Scand, vol.83, pp.280-285, 1991.

, Standard Country or Area Codes for Statistical Use, 1999.

, Licence CC BY

, Census Data Products: United States, 2010.

D. Valenzuela, P. Zitko, and P. Lillo, Amyotrophic lateral sclerosis mortality rates in Chile: A population based study, Amyotroph. Lateral Scler. Front. Degener, vol.16, pp.372-377, 1994.

J. Valle, E. Roberts, S. Paulukonis, N. Collins, P. English et al., Epidemiology and surveillance of amyotrophic lateral sclerosis in two large metropolitan areas in California, Amyotroph. Lateral Scler. Front. Degener, vol.16, pp.209-215, 2015.

M. A. Van-es, C. Dahlberg, A. Birve, J. H. Veldink, . Van-den et al., Large-scale SOD1 mutation screening provides evidence for genetic heterogeneity in amyotrophic lateral sclerosis, J. Neurol. Neurosurg. Psychiatry, vol.81, pp.562-566, 2010.

M. A. Van-es, O. Hardiman, A. Chio, A. Al-chalabi, R. J. Pasterkamp et al., Amyotrophic lateral sclerosis, Lancet Lond. Engl, vol.390, pp.2084-2098, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01784633

P. W. Van-vught, N. A. Sutedja, J. H. Veldink, B. P. Koeleman, G. J. Groeneveld et al., Lack of association between VEGF polymorphisms and ALS in a Dutch population, Neurology, vol.65, pp.1643-1645, 2005.

,

J. P. Vandenbroucke, . Elm, D. G. Altman, P. C. Gøtzsche, C. D. Mulrow et al., Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration, PLOS Med, vol.4, 2007.

M. C. Vázquez, C. Ketzoián, C. Legnani, I. Rega, N. Sánchez et al., Incidence and prevalence of amyotrophic lateral sclerosis in Uruguay: a population-based study, Neuroepidemiology, vol.30, pp.105-111, 2008.

J. H. Veldink, S. Kalmijn, G. Groeneveld, W. Wunderink, A. Koster et al., Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis, J. Neurol. Neurosurg. Psychiatry, vol.78, pp.367-371, 2007.

M. Vinceti, F. Bonvicini, K. J. Rothman, L. Vescovi, and F. Wang, The relation between amyotrophic lateral sclerosis and inorganic selenium in drinking water: a populationbased case-control study, Environ. Health Glob. Access Sci. Source, vol.9, 2010.

M. Vinceti, D. Guidetti, M. Bergomi, E. Caselgrandi, R. Vivoli et al., Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis, Ital. J. Neurol. Sci, vol.18, pp.87-92, 1997.

J. Visser, R. M. Van-den-berg-vos, H. Franssen, . Van-den, L. H. Berg et al., Disease course and prognostic factors of progressive muscular atrophy, Arch. Neurol, vol.64, pp.522-528, 2007.

E. Vittinghoff, D. V. Glidden, S. C. Shiboski, and C. E. Mcculloch, Regression Methods in Biostatistics: Linear, Logistic, Survival, and Repeated Measures Models, 2012.

D. W. Wall and M. Gelfand, Motor neuron disease in Rhodesian Africans, Brain J. Neurol, vol.95, pp.517-520, 1972.

, Licence CC BY

H. Wang, A. A. Abajobir, K. H. Abate, C. Abbafati, K. M. Abbas et al.,

P. N. Keiyoro, S. G. Kelbore, A. H. Kemp, A. P. Kengne, A. Keren et al.,

B. H. Sobngwi, E. Soneji, S. Soriano, J. B. Sreeramareddy, C. T. Srinivasan et al., Global, regional, and national under-5 mortality, The Lancet, vol.390, issue.17, pp.31833-31833, 2016.

H. Wang, É. J. O'reilly, M. G. Weisskopf, G. Logroscino, M. L. Mccullough et al., Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts, Arch. Neurol, vol.68, pp.207-213, 2011.

M. G. Weisskopf, E. J. O'reilly, M. L. Mccullough, E. E. Calle, M. J. Thun et al., Prospective study of military service and mortality from ALS, Neurology, vol.64, pp.32-37, 2005.

L. C. Werneck, R. Bezerra, O. Silveira-neto, . Da, and R. H. Scola, A clinical epidemiological study of 251 cases of amyotrophic lateral sclerosis in the south of Brazil, Arq. Neuropsiquiatr, vol.65, pp.189-195, 2007.

L. C. Wijesekera, S. Mathers, P. Talman, C. Galtrey, M. H. Parkinson et al., Natural history and clinical features of the flail arm and flail leg ALS variants, Neurology, vol.72, pp.1087-1094, 2009.

, International Statistical Classification of Diseases and Related Health Problems, vol.2, 2010.

, World Health Organization, the World Federation of Neurology, 2017.

W. Willis, A. Evanoff, B. A. Lian, M. Criswell, S. R. Racette et al., Geographic and Ethnic Variation in Parkinson Disease: A Population-Based Study of US Medicare Beneficiaries, Neuroepidemiology, vol.34, pp.143-151, 2010.

T. Zaldivar, J. Gutierrez, G. Lara, M. Carbonara, G. Logroscino et al., Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study, Neurology, vol.72, pp.1640-1645, 2009.

,

Y. Zhang, H. Zhang, Y. Fu, H. Song, L. Wang et al., VEGF C2578A polymorphism does not contribute to amyotrophic lateral sclerosis susceptibility in sporadic Chinese patients, Amyotroph. Lateral Scler. Off. Publ. World Fed. Neurol. Res. Group Mot. Neuron Dis, vol.7, pp.119-122, 2006.

H. Zhou, G. Chen, C. Chen, Y. Yu, and Z. Xu, Association between extremely lowfrequency electromagnetic fields occupations and amyotrophic lateral sclerosis: a meta-analysis, PloS One, vol.7, 2012.

S. Zoccolella, E. Beghi, G. Palagano, A. Fraddosio, V. Guerra et al., ALS multidisciplinary clinic and survival. Results from a population-based study in Southern Italy, J. Neurol, vol.254, pp.1107-1112, 2007.

Z. Zou, Z. Zhou, C. Che, C. Liu, R. He et al., Genetic epidemiology of amyotrophic lateral sclerosis: a systematic review and meta-analysis, 2017.

, J. Neurol. Neurosurg. Psychiatry, vol.88, pp.540-549

, Male, vol.20, p.795, 4116.

, Female, vol.19, p.693, 7863.